Edition:
India

Roche Holding AG (ROG.S)

ROG.S on Virt-X Level 1

242.90CHF
21 Aug 2018
Change (% chg)

CHF0.90 (+0.37%)
Prev Close
CHF242.00
Open
CHF241.40
Day's High
CHF243.95
Day's Low
CHF241.40
Volume
1,201,874
Avg. Vol
1,684,412
52-wk High
CHF252.85
52-wk Low
CHF206.35

Chart for

About

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas:... (more)

Overall

Beta: 0.97
Market Cap(Mil.): CHF214,033.70
Shares Outstanding(Mil.): 862.56
Dividend: 8.20
Yield (%): 3.31

Financials

  ROG.S Industry Sector
P/E (TTM): 22.03 30.93 32.76
EPS (TTM): 11.25 -- --
ROI: 20.46 15.07 14.61
ROE: 46.88 16.59 16.33

Roche's Alecensa latest beneficiary of faster China drug approvals

ZURICH Roche's Alecensa lung cancer medicine became the latest beneficiary of China's efforts to speed up approvals in the world's second-biggest drug market, which is gaining importance for global pharmaceuticals companies' growth plans.

20 Aug 2018

Roche's Alecensa latest beneficiary of faster China drug approvals

ZURICH, Aug 20 Chinese regulators are speeding up drug approvals, with Roche's Alecensa cancer medicine the latest beneficiary in a market that is growing increasingly important for international pharmaceuticals companies' growth plans.

20 Aug 2018

Pfizer bets on biotech flu vaccine in $425 million BioNTech alliance

FRANKFURT Pfizer has agreed to pay German biotech firm BioNTech up to $425 million in an alliance to develop more effective influenza jabs, the latest among several major pharma companies to bank on a promising new genetic approach.

16 Aug 2018

Pfizer bets on biotech flu vaccine in $425 mln BioNTech alliance

FRANKFURT, Aug 16 Pfizer has agreed to pay German biotech firm BioNTech up to $425 million in an alliance to develop more effective influenza jabs, the latest among several major pharma companies to bank on a promising new genetic approach.

16 Aug 2018

Bank DNB switches US, Europe mutual funds to index tracking

OSLO, Aug 14 Norwegian bank DNB will switch its mutual funds for U.S. and European stocks to index tracking from active management on Aug. 16, it said on Tuesday.

14 Aug 2018

Swiss stocks - Factors to watch on July 27

ZURICH, July 27The Swiss blue-chip SMI was seen opening 0.1 percent down at 9,135 points on Friday, according to premarket indications by bank Julius Baer .

27 Jul 2018

UPDATE 1-Switzerland's Vontobel lifts 2020 goals after buying private bank Notenstein

* CEO sees profitability hike, despite difficult markets (Adds comment from CEO, details throughout)

27 Jul 2018

Roche lifts veil on patent that earned it billions but soon expires

ZURICH Roche on Thursday lifted its veil of secrecy over a patent that has reaped billions of dollars over the years but is due to expire on Dec. 18, depriving the Swiss drugmaker of a key source of income.

26 Jul 2018

Roche lifts veil on patent that earned it billions but soon expires

ZURICH, July 26 Roche on Thursday lifted its veil of secrecy over a patent that has reaped billions of dollars over the years but is due to expire on Dec. 18, depriving the Swiss drugmaker of a key source of income.

26 Jul 2018

UPDATE 1-Roche raises 2018 outlook as new drugs gain traction

ZURICH, July 26 Swiss drugmaker Roche lifted its 2018 outlook on Thursday for the second time this year, after first-half sales and profit easily beat analysts' expectations on the strength of newer drugs, including multiple sclerosis treatment Ocrevus.

26 Jul 2018

Earnings vs. Estimates